Circe Biomedical

About:

Circe Biomedical is a Biotechnology company.

Top Investors: Polaris Partners, Advanced Technology Ventures, Burrill & Company, HLM Management Company

Description:

Circe Biomedical, Inc. develops, produces, and commercializes bioartificial organ systems. It develops bioartificial organs from isolated mammalian cells and membranes for patients suffering from acute, end-stage liver failure. The company also develops PancreAssist System, an implantable, bioartificial pancreas for severe insulin-dependent diabetics. Circe Biomedical, Inc. was incorporated in 1999 and is based in Lexington, Massachusetts.

Total Funding Amount:

$28M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

1999-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2000-12-18

IPO Status:

Private

Industries: